Hi sheila. I've been having a good look around the various articles on this and it seems that there are no recent trials. I have found this
https://www.gov.uk/drug-safety-update/tibolone-benefit-risk-balance#:~:text=For%20women%20older%20than%20about,for%20women%20with%20a%20uterus. but also found another article that seems to show the risk of stroke is higher but this is then shown in a BMS article to be due to flawed interpretation of results. This is an extract "The increased risk of stroke with tibolone has also been reported with estrogen therapy,20,39 but the biologic mechanism is not certain. A randomized, placebo-controlled trial showed that 2.5 mg of tibolone and conjugated equine estrogen plus medroxyprogesterone slightly increased the intima–media thickness by 0.004 mm per year.40 Tibolone increases levels of C-reactive protein, a risk factor for stroke, to a degree similar to that of conjugated equine estrogen.41 In randomized trials, tibolone decreased HDL cholesterol levels but improved lipoprotein(a) levels, did not significantly change homocysteine levels, and increased plasminogen levels.41,42 Treatment with tibolone had no effect on blood pressure or fasting blood glucose levels.40
Since the risk of stroke rises exponentially with age, tibolone should generally not be used in elderly women. Tibolone has been used by women between the ages of 50 and 60 years for menopausal symptoms and the prevention of osteoporosis when the risk of stroke was low, but it should be avoided in women who have strong risk factors for stroke, such as hypertension, smoking, diabetes, and atrial fibrillation.43 Although the overall number of adverse events was small, there was no increased risk of venous thromboembolism, as has been seen with hormone therapy and SERMs, or an increased risk of coronary events, as has been seen with conjugated estrogen combined with medroxyprogestrone"
Whole article here
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3684062/ The BMS article
https://thebms.org.uk/2008/08/tibolone-risks-and-benefits-in-older-women/As you say it is odd that its for post menopausal women yet could seem to be risky in over 60s. Most of the trials seem to stop at age 59. It is obviously good for bone strength and reducing the risk of fractures. Seemingly reducing the risk of breast cancer and other cancers too. The latest PIL doesn't really contraindicate use in over 60's so maybe the advice has been updated?
Taz x